Company Rapid Therapeutic Science Laboratories, Inc. Other OTC
Equities
RTSL
US7534311052
Pharmaceuticals
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Donal Schmidt
CEO | Chief Executive Officer | 63 | 14/11/19 |
D. Watler
DFI | Director of Finance/CFO | 75 | 14/11/19 |
Sean P. Berrier
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
D. Watler
DFI | Director of Finance/CFO | 75 | 14/11/19 |
Donal Schmidt
CEO | Chief Executive Officer | 63 | 14/11/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 20,910,251 | 15,769,465 ( 75.41 %) | 0 | 75.41 % |
Company contact information
Rapid Therapeutic Science Laboratories, Inc.
558 County Road Suite 472
76444, De Leon
+
Sector
1st Jan change | Capi. | |
---|---|---|
+42.38% | 6.26B | |
-15.86% | 4.49B | |
+6.36% | 3.29B | |
-11.28% | 3.12B | |
-3.23% | 2.5B | |
+45.24% | 1.94B | |
-7.89% | 1.68B | |
-0.98% | 1.63B | |
-11.32% | 1.56B |